Front Endocrinol 13:1033479 Edison P et al (2021) Evaluation of liraglutide in the treatment of Alzheimers disease
Iwaya C, Nomiyama T, Komatsu S, Kawanami T, Tsutsumi Y, Hamaguchi Y, Horikawa T, Yoshinaga Y, Yamashita S, Tanaka T, Terawaki Y, Tanabe M, Nabeshima K, Iwasaki A, Yanase T (2017) Exendin-4, a glucagonlike peptide-1 receptor agonist, attenuates breast cancer growth by inhibiting NF-kappaB activation
Learn about Semaglutide (Ozempic/Wegovy) dosing, side effects, costs, and FDA approval status
Some prescribe GLP-1s to treat binge eating disorder a serious condition involving rapidly eating large meals with a loss of control, followed by feelings of intense shame despite these drugs not being approved for that purpose, says Elliott
GLP-1 agonists improve insulin sensitivity directly, independent of weight loss, which further reduces aromatase-driven estrogen production
In contrast, blocking muscle NF-kB activation prevents inflammatory and atrophy signaling in skeletal muscle, resulting in significant muscle mass preservation in response to systemic inflammation (Langen et al., 2012)
